Triple-Negative Breast Cancer Research and Education Act of 2025
- Sponsor
- Rep. Morelle, Joseph D. [D-NY-25]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Mar 3, 2025
Bottom line
The bill aims to increase understanding, awareness, and treatment information for triple-negative breast cancer, with a specific focus on addressing disparities affecting minority women.
What it actually does
This bill directs the National Institutes of Health (NIH) to expand and coordinate research into triple-negative breast cancer (TNBC), particularly focusing on its prevalence and impact on minority women. It also mandates the Department of Health and Human Services (HHS), through the CDC and HRSA, to develop and disseminate public education and information for healthcare providers about TNBC, its elevated risk in minority women, and treatment options.
Proponents argue
Supporters argue this bill is crucial for addressing a significant health disparity, as triple-negative breast cancer is an aggressive form that disproportionately affects African-American and Hispanic women and lacks targeted therapies. By expanding research and public education, the bill can lead to earlier detection, improved treatment strategies, and ultimately, better survival rates for affected populations.
Opponents contend
Critics might argue that while the intent is laudable, authorizing "such sums as may be necessary" without specific appropriations figures could lead to unpredictable federal spending. Some might also contend that existing NIH and CDC programs could already address these issues without new, specific legislation, potentially leading to redundant efforts or inefficient allocation of resources.
The bill is very short and clearly written, making it highly accessible for any reader to understand its provisions and implications within a few minutes.
Section 3(a)
Expansion of Triple-Negative Breast Cancer Research
This provision directs the National Institutes of Health (NIH) to significantly increase and better organize its research efforts specifically targeting triple-negative breast cancer (TNBC). It specifies that this research should be conducted through various relevant NIH institutes, including those focused on child health, environmental health, women's health, and minority health disparities, with coordination led by the Office of Research on Women's Health. The goal is to fill gaps in understanding TNBC, especially concerning its prevalence, costs, prevention, and cure methods in minority women.
Supporters argue
Supporters argue that dedicated and coordinated research is essential to combat TNBC, especially given its aggressive nature and disproportionate impact on minority women. This provision ensures that federal research efforts are specifically targeted to address the unique challenges of TNBC, which currently lacks effective targeted therapies.
Critics contend
Some might argue that directing specific research areas could limit the flexibility of NIH to allocate resources based on evolving scientific priorities and broader public health needs. They might suggest that existing mechanisms for funding cancer research are sufficient without earmarking funds for a specific subtype.
Tradeoffs
The tension lies between directing federal research towards a specific, high-need area (TNBC) versus allowing broader scientific discretion in funding allocation. While targeted research can yield focused results, it might draw resources from other important, less-specified research areas.
Section 3(b)
Public Education and Information Dissemination
This provision mandates the Secretary of Health and Human Services (HHS), acting through the Centers for Disease Control and Prevention (CDC), to create and distribute information to the public about triple-negative breast cancer. This information must cover the incidence and prevalence of TNBC, the elevated risk for minority women, and the available treatment options. The dissemination can occur directly or through partnerships with non-profit organizations, consumer groups, educational institutions, government agencies, or media outlets.
Section 3(c)
Information Dissemination to Health Care Providers
This provision requires the Secretary of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), to develop and distribute information to healthcare providers about triple-negative breast cancer. The purpose is to keep providers updated on the latest information, including the elevated risk for minority women and the range of treatment options for symptomatic TNBC.
Defines "minority women" as women who are members of a racial and ethnic minority group, as defined in section 1707(g) of the Public Health Service Act.
Section 3(d)
Why it matters:This is standard legislative practice for incorporating existing definitions by reference, rather than re-stating lengthy statutory text. It's not necessarily evasive but requires external lookup.
Case for: Using existing statutory definitions ensures consistency across federal law and avoids creating new, potentially conflicting definitions for established terms.
Case against: For a reader unfamiliar with the Public Health Service Act, this cross-reference makes the bill less self-contained and requires additional research to fully grasp which groups are specifically targeted by the bill's provisions.
Estimated impact: Clarifies the specific demographic groups (racial and ethnic minority women) that are the focus of the bill's targeted research and education efforts.